FDA approves Merck's Winrevair | Drug Store News drugstorenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from drugstorenews.com Daily Mail and Mail on Sunday newspapers.
Adults with pulmonary arterial hypertension (PAH) have a new treatment available with the FDA approval of sotatercept (Winrevair; Merck), an activin signaling inhibitor biologic.
Merck Drug for Heart and Lung Disorder Wins a First-in-Class FDA Approval medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.
WINREVAIR on top of background therapy significantly improved exercise capacity and multiple important secondary outcome measures compared to background therapy alone
First-in-class biologic approved for rare lung disease europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.